Kramer MW - Search Results

1

[Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance].

Hupe MC, Müller M, Struck JP, Wießmeyer JR, Ozimek T, Steuber T, Gschwend J, Hammerer P, Kramer MW, Merseburger AS. Hupe MC, et al. Among authors: kramer mw. Aktuelle Urol. 2022 Feb;53(1):43-53. doi: 10.1055/a-1332-8625. Epub 2021 Jun 1. Aktuelle Urol. 2022. PMID: 34062565 German.

2

Tissue microarrays in clinical urology--technical considerations.

Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M. Kramer MW, et al. Scand J Urol Nephrol. 2007;41(6):478-84. doi: 10.1080/00365590701430737. Scand J Urol Nephrol. 2007. PMID: 17907050 Review.

3

Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.

Merseburger AS, Kramer MW, Hennenlotter J, Simon P, Knapp J, Hartmann JT, Stenzl A, Serth J, Kuczyk MA. Merseburger AS, et al. Among authors: kramer mw. Prostate. 2008 Jan 1;68(1):72-7. doi: 10.1002/pros.20688. Prostate. 2008. PMID: 18008332

4

An update on the medical therapy of advanced metastatic renal cell carcinoma.

Kruck S, Merseburger AS, Gakis G, Kramer MW, Stenzl A, Kuczyk MA. Kruck S, et al. Among authors: kramer mw. Scand J Urol Nephrol. 2008;42(6):501-6. doi: 10.1080/00365590802203983. Scand J Urol Nephrol. 2008. PMID: 18615363 Review.

5

Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update.

Kruck S, Kuczyk MA, Gakis G, Kramer MW, Stenzl A, Merseburger AS. Kruck S, et al. Among authors: kramer mw. Rev Recent Clin Trials. 2008 Sep;3(3):212-6. doi: 10.2174/157488708785700311. Rev Recent Clin Trials. 2008. PMID: 18782079 Review.

6

Present state of target therapy for disseminated renal cell carcinoma.

Waalkes S, Kramer M, Herrmann TR, Schrader AJ, Kuczyk MA, Merseburger AS. Waalkes S, et al. Immunotherapy. 2010 May;2(3):393-8. doi: 10.2217/imt.10.14. Immunotherapy. 2010. PMID: 20635903 Review.

7

Can aquaporin-1 and adipophilin in urine distinguish between malignant and nonmalignant renal lesions?

Kramer MW, Merseburger AS, Tezval H. Kramer MW, et al. Mayo Clin Proc. 2010 Aug;85(8):768; author reply 768-9. doi: 10.4065/mcp.2010.0290. Mayo Clin Proc. 2010. PMID: 20675516 Free PMC article. No abstract available.

8

[Targeted therapy of urological tumours. Experimental field or established therapeutic approach?].

Kramer MW, Krege S, Peters I, Merseburger AS, Kuczyk MA. Kramer MW, et al. Urologe A. 2010 Oct;49(10):1260-5. doi: 10.1007/s00120-010-2397-2. Urologe A. 2010. PMID: 20848076 Review. German.

9

Does male sex influence the prognosis of patients with renal cancer?

Waalkes S, Rott H, Herrmann TR, Wegener G, Kramer MW, Merseburger AS, Schrader M, Hofmann R, Kuczyk MA, Schrader AJ. Waalkes S, et al. Among authors: kramer mw. Onkologie. 2011;34(1-2):24-8. doi: 10.1159/000323379. Epub 2011 Jan 24. Onkologie. 2011. PMID: 21346381

10

[Systemic and surgical management of metastatic renal cell carcinoma].

Kramer MW, Merseburger AS, Peters I, Waalkes S, Kuczyk MA. Kramer MW, et al. Urologe A. 2012 Feb;51(2):217-25. doi: 10.1007/s00120-011-2713-5. Urologe A. 2012. PMID: 22009257 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters